Opening Pandora’s Box could solve medicine shortages

Breen and Vann Yaroson explore why they must minimise the disruption of medicine supply. According to the ongoing research, there are fundamental problems with the supply chain -- and most of them do not involve Brexit at all. It is certainly true that the indecision around Brexit has spilled over i...

Full description

Saved in:
Bibliographic Details
Published in:Logistics and Transport Focus 2018-12, Vol.20 (12), p.36
Main Authors: Breen, Liz, Yaroson, Emilia Vann
Format: Article
Language:English
Subjects:
Decision making
Pharmaceutical industry
Supply chain management
Supply chains
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Breen and Vann Yaroson explore why they must minimise the disruption of medicine supply. According to the ongoing research, there are fundamental problems with the supply chain -- and most of them do not involve Brexit at all. It is certainly true that the indecision around Brexit has spilled over into the pharmaceutical supply chain where concerns over the continuity of medicines are rife. Here, decisions need to be taken to ensure the disruption of medicines supplied to patients is minimised or eradicated. Both the NHS and the pharmaceutical industry need to ensure that these vital -- and sometimes lifesaving -- products are available for patients.
ISSN:1466-836X